Thank you for your interest in the upcoming challenge.
PrecisionFDA and FDA’s National Center for Toxicological Research (NCTR) have teamed up to launch the NCTR Indel Calling from Oncopanel Sequencing Data Challenge. This challenge asks participants to develop, validate, and benchmark indel calling pipelines to identify indels in the oncopanel sequencing datasets generated by the SEQC2 Oncopanel Sequencing Working Group. To get the most up to date information and to be notified when it launches, please provide the following information. For more information, visit the precisionFDA Challenge Site.